Published 02-07-24
Issued by Novartis
The latest Novartis in Society Integrated Report provides an overview of the company’s business and ESG performance in 2023 and describes how it creates sustainable value for stakeholders and society.
Novartis delivered a strong performance in 2023, advancing new treatments for serious diseases and broadening access to our medicines. Our performance highlights the progress we are making in delivering on our purpose to reimagine medicine to improve and extend people’s lives.
The Novartis in Society Integrated Report 2023, published on January 31, describes how we create sustainable value for our stakeholders by embedding material environmental, social and governance (ESG) topics into the core of our business.
It contains comprehensive information and data on our progress in 2023 – including in innovation, access to medicines, advancing gender equity, strengthening our ethical culture, and reducing our impact on the environment.
2023 HIGHLIGHTS
Commenting on the company’s 2023 performance, Novartis Chief Executive Officer Vas Narasimhan said: “We continued to deliver on our commitments to broaden access to our innovative medicines, tackle major global health challenges, advance gender equity, and reduce our impact on the environment. Looking ahead, we aim to build on this momentum and bring the same dedication to innovation and excellence to create sustainable value for patients, for society, and for our shareholders.”
The Novartis in Society Integrated Report is intended for all Novartis stakeholders, while meeting the needs of ESG professionals through comprehensive and downloadable data on our performance.
The report was prepared in accordance with Art. 964b of the Swiss Code of Obligations, and in alignment with recommendations and standards issued by the Integrated Reporting Framework, the Sustainability Accounting Standards Board (SASB), the Global Reporting Initiative (GRI), and the Task Force on Climate-related Financial Disclosures (TCFD).
Access and download the full report at: novartis.com/investors/reporting-and-transparency-hub/novartis-society-integrated-report
Novartis Media Relations
E-mail: media.relations@novartis.com
This document contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. For more information, please see the full Novartis in Society Integrated Report 2023.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.